Bullseye Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Sell
2,107
-473
-18% -$483K 1.24% 18
2026
Q1
$2.37M Sell
2,580
-42
-2% -$42.6K 1.28% 19
2025
Q4
$2.82M Buy
+2,622
New +$2.51M 1.47% 17
2024
Q4
Sell
-249
Closed -$207K 86
2024
Q3
$207K Sell
249
-52
-17% -$46.8K 0.12% 60
2024
Q2
$273K Buy
301
+14
+5% +$11.2K 0.18% 56
2024
Q1
$223K Buy
+287
New +$204K 0.13% 51
2023
Q1
Sell
-5,177
Closed -$1.89M 56
2022
Q4
$1.89M Buy
+5,177
New +$1.84M 1.57% 27

Other funds holding LLY

Bullseye Investment Management's LLY Position: Q2 2026 in Review

Bullseye Investment Management reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $483K and leaving 2,107 shares worth $2.53M. The position accounts for 1.24% of the portfolio, ranked #18.

Bullseye Investment Management first reported a position in LLY in Q4 2022 and has held it in 7 quarters since. The position peaked at $2.82M in Q4 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bullseye Investment Management held 2,107 shares of Eli Lilly worth $2.53M as of Q2 2026.
  • Bullseye Investment Management sold 473 Eli Lilly shares in Q2 2026, an estimated $483K.
  • Eli Lilly made up 1.24% of Bullseye Investment Management's portfolio in Q2 2026, its #18 holding.
  • Bullseye Investment Management first reported a position in Eli Lilly in Q4 2022 and has held it in 7 quarters since.
  • Bullseye Investment Management's Eli Lilly position peaked at $2.82M in Q4 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bullseye Investment Management's 13F filing for Q2 2026, filed 11 Sep 2026.